Enterobiotix announces new Executive appointments

Feb 2024

As it drives growth and advances its global leadership in the microbiome field, investee company EnteroBiotix has made two senior appointments. James Barnes joins as Chief Operating Officer, bringing a wealth of experience in early and late phase drug development and business operations. As the new Chief Financial Officer, Chris Lea has strong experience across the industry and will help to expand the business.

Read for the full PR on the Enterobiotix website

Categorised as 2024, News